Prevalence of potential drug-drug interactions in patients of the Swiss HIV cohort study in the era of HIV integrase inhibitors

被引:0
|
作者
Deutschmann, E. [1 ,2 ]
Bucher, H. C. [1 ,2 ,3 ,4 ,5 ]
Jaeckel, S. [6 ]
Gibbons, S. [7 ]
McAllister, K. [7 ]
Scherrer, A. [8 ,9 ,10 ]
Braun, D. [8 ,9 ]
Cavassini, M. [11 ]
Hachfeld, A. [12 ]
Calmy, A. [13 ]
Battegay, M. [3 ,4 ,5 ]
Cipriani, M. [14 ,15 ]
Elzi, L. [16 ]
Young, J. [1 ,2 ]
Lopez-Centeno, B. [17 ]
Berenguer, J. [18 ]
Khoo, S. [7 ]
Moffa, G. [1 ,2 ]
Marzolini, C. [3 ,4 ,5 ,7 ]
机构
[1] Univ Basel, Inst Clin Epidemiol & Biostat, Dept Clin Res, Basel, Switzerland
[2] Univ Basel, Univ Hosp, Basel, Switzerland
[3] Univ Hosp, Div Infect Dis, Basel, Switzerland
[4] Univ Hosp, Hosp Epidemiol, Basel, Switzerland
[5] Univ Basel, Basel, Switzerland
[6] EYE T Serv, Freiburg, Germany
[7] Univ Liverpool, Dept Pharmacol, Liverpool, Merseyside, England
[8] Univ Zurich, Univ Hosp, Div Infect Dis, Zurich, Switzerland
[9] Univ Zurich, Univ Hosp, Hosp Epidemiol, Zurich, Switzerland
[10] Univ Zurich, Inst Med Virol, Zurich, Switzerland
[11] Univ Hosp Lausanne, Div Infect Dis, Lausanne, Switzerland
[12] Univ Hosp Bern, Div Infect Dis, Bern, Switzerland
[13] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland
[14] Canton Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland
[15] Canton Hosp St Gallen, Hosp Epidemiol, St Gallen, Switzerland
[16] Osped Regionale Bellinzona & Valli, Bellinzona, Switzerland
[17] Serv Madrileno Salud SERMAS, Subdirecc Gen Farm & Prod Sanitarios, Madrid, Spain
[18] Hosp Gen Univ Gregorio Maranon IiSGM, Madrid, Spain
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
PS13/3
引用
收藏
页码:40 / 40
页数:1
相关论文
共 50 条
  • [1] Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors
    Deutschmann, Elisabeth
    Bucher, Heiner C.
    Jaeckel, Steffen
    Gibbons, Sara
    McAllister, Katie
    Scherrer, Alexandra U.
    Braun, Dominique L.
    Cavassini, Matthias
    Hachfeld, Anna
    Calmy, Alexandra
    Battegay, Manuel
    Cipriani, Michela
    Elzi, Luigia
    Young, James
    Lopez-Centeno, Beatriz
    Berenguer, Juan
    Khoo, Saye
    Moffa, Giusi
    Marzolini, Catia
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2145 - E2152
  • [2] Prevalence of potential drug-drug interactions in the Swiss HIV Cohort Study
    Marzolini, C.
    Gibbons, S.
    Elzi, L.
    Ledergerber, B.
    Battegay, M.
    Back, D.
    HIV MEDICINE, 2009, 10 : 52 - 52
  • [3] Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study
    Baecke, C.
    Gyssens, I. C.
    Decoutere, L.
    van der Hilst, J. C. H.
    Messiaen, P.
    NETHERLANDS JOURNAL OF MEDICINE, 2017, 75 (06): : 235 - 240
  • [4] Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
    Marzolini, Catia
    Elzi, Luigia
    Gibbons, Sara
    Weber, Rainer
    Fux, Christoph
    Furrer, Hansjakob
    Chave, Jean-Philippe
    Cavassini, Matthias
    Bernasconi, Enos
    Calmy, Alexandra
    Vernazza, Pietro
    Khoo, Saye
    Ledergerber, Bruno
    Back, David
    Battegay, Manuel
    ANTIVIRAL THERAPY, 2010, 15 (03) : 413 - 423
  • [5] Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study
    Altunal, Lutfiye Nilsun
    Caglayik, Dilek Yagci
    Ozel, Ayse Serra
    Tigen, Elif Tukenmez
    Sili, Uluhan
    Sengel, Buket Erturk
    Aydin, Mehtap
    Korten, Volkan
    AIDS PATIENT CARE AND STDS, 2023, 37 (03) : 138 - 145
  • [6] Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors
    Yesilbag, Zuhal
    Sengul, Emine Ilay
    Senoglu, Sevtap
    Aydin, Ozlem Altuntas
    Karaosmanoglu, Hayat Kumbasar
    CURRENT HIV RESEARCH, 2020, 18 (06) : 415 - 425
  • [7] An analysis of potential drug-drug interactions in an aging HIV cohort
    Gardiner, P.
    Rizzo, G.
    O'Donovan, M.
    HIV MEDICINE, 2019, 20 : 127 - 127
  • [8] Switching to High Genetic Barrier Integrase Inhibitors Reduces Drug-Drug Interactions in People Living With HIV
    Askari, Ara
    Nashier, Chhavi
    Ghelani, Rahul
    Vargas Zhang, Adrian
    Ng, Megan
    Karagozlu, Zekiye
    Bracchi, Margherita
    Moyle, Graeme
    Asboe, David
    Boffito, Marta
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 92 (04) : E19 - E20
  • [9] Switching to high genetic-barrier integrase inhibitors reduces drug-drug interactions in people living with HIV
    Nashier, Chhavi
    Askari, Ara
    Ghelani, Rahul
    Zhang, Adrian Vargas
    Ng, Megan
    Karagozlu, Zekiye
    Bracchi, Margherita
    Moyle, Graeme
    Asboe, David
    Boffito, Marta
    HIV MEDICINE, 2023, 24 : 24 - 24
  • [10] Drug-drug interactions in HIV positive cancer patients
    Flepisi, Brian Thabile
    Bouic, Patrick
    Sissolak, Gerhard
    Rosenkranz, Bernd
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (05) : 665 - 677